Subscribe To
Neurocrine's crinecerfont delivered, but the street has been slow to reward the success
Neurocrine Biosciences has reported very positive Phase iii results for crinecerfont in adult and pedia...
October 11, 2023, 3:44 am
Roche's (rhhby) vabysmo positive in late-stage rvo studies
Roche (RHHBY) Vabysmo maintains vision improvements with extended treatment intervals of up to four months in phase...
October 10, 2023, 1:32 pm
Merck immunotherapy shows further promise in lung cancer
Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary targets in a phase...
October 10, 2023, 9:11 am
5 low price-to-sales stocks poised to deliver robust value
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, JAKK, ...
October 6, 2023, 9:46 am
Top 3 momentum anomaly picks as high treasury yields take toll
Astec (ASTE), Dream Finders (DFH) and G-III Apparel (GIII) are currently witnessing a short-term pullback in price. So, make sure you take full advant...
October 6, 2023, 9:46 am
Merck blockbuster shows promise in bladder cancer
Merck & Co Inc (NYSE:MRK) has announced promising results from its phase iii clinical trial of its bloc...
October 5, 2023, 8:43 am
Eurusd short term rally still expected to fail
Short Term Elliott Wave in EURUSD suggests cycle from 8.30.2023 high is in progress as a 5 waves impulse. Down from 8.30.2023 high, wave ((i)) ended a...
October 5, 2023, 4:22 am
3 explosive cannabis stocks that will make early investors rich
While the adult botanical industry presents high risks, regulatory momentum may bolster the case of cannabis stocks to make you rich. Specifically, a ...
October 3, 2023, 8:29 pm
Novartis (nvs) announces positive data on kidney disease drug
Novartis' (NVS) phase iii study on pipeline candidate iptacopan in patients with IgAN shows superiority...
October 3, 2023, 1:32 pm
G-iii apparel (giii) stock soars more than 80% ytd: here's why
G-III Apparel's (GIII) brand power and solid business strategies appear encouraging. Its digital business also looks good....
October 3, 2023, 12:46 pm
Top 5 high-flying nasdaq stocks defying index's recent turmoil
We have narrowed our search to five Nasdaq Composite-listed stocks that have popped more than 10% in the past month. These are: VIRC, GIII, SIGA, DUOL...
October 3, 2023, 11:17 am
Is giii apparel group (giii) stock undervalued right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 3, 2023, 11:16 am
Why fast-paced mover g-iii apparel (giii) is a great choice for value investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, G-III Apparel (GIII) could be a gr...
October 2, 2023, 10:34 am
Roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd
Basel, 02 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new data for OCREVUS® (ocrelizumab) and investigational Bruton's tyrosine ki...
October 2, 2023, 1:00 am
Ticking time bombs: 3 cannabis stocks to dump before the damage is done
The North American cannabis market is booming in 2023, thanks to the legalization of recreational and medical marijuana in several states and province...
October 1, 2023, 5:30 pm
Baudax bio shares rocket as lead clinical candidate gains fda orphan drug designation
Shares of Baudax Bio added 80% after it announced its lead clinical candidate targeting Hemophilia A with inhibitors has been awarded orphan drug stat...
September 28, 2023, 12:27 pm
Novartis (nvs) lutathera meets primary goal in phase iii study
Novartis' (NVS) radioligand therapy Lutathera reports statistically significant and clinically meaningful progression-free survival in first line adva...
September 25, 2023, 1:32 pm
Lloyds banking group lower on reports reforms to be delayed
Lloyds Banking Group PLC (LSE:LLOY) shares eased after reports the Bank of England is to delay implementing the latest package of global post-crisis b...
September 25, 2023, 7:32 am
Week in review: everest acquires novel autoimmune therapy in $132 million agreement
Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a...
September 24, 2023, 10:33 pm
Banco de chile: excellent bank at a fair price in a declining rates environment
Banco de Chile is probably the best Chilean bank, given its balance sheet quality, excellent efficiency ratio, and outstanding Basel...
September 22, 2023, 3:13 pm